Manufacturer
Otsuka America Pharmaceutical
Pharmaceutical manufacturer based in Japan
Japan
- Products listed
- 26
- Molecules
- 6
- Therapy areas
- 3
Otsuka America Pharmaceutical is a pharmaceutical manufacturer based in Japan. MedsAcross lists 26 of its products across 6 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- Japan
- Indian manufacturer
- No
- Also listed as
- Otsuka America Pharmaceutical, Inc, Otsuka America Pharmaceutical, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Otsuka America Pharmaceutical products through licensed channels, with the documents your regulator needs.
Psychiatry
16 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Abilify 10 mg tabletOral | Aripiprazole | US FDA | Available on request |
| Abilify 15 mg tabletOral | Aripiprazole | US FDA | Available on request |
| Abilify 2 mg tabletOral | Aripiprazole | US FDA | Available on request |
| Abilify 20 mg tabletOral | Aripiprazole | US FDA | Available on request |
| Abilify 30 mg tabletOral | Aripiprazole | US FDA | Available on request |
| Abilify 5 mg tabletOral | Aripiprazole | US FDA | Available on request |
| Abilify Asimtufii 720 mg/2.4 mL extended-release injectable suspensionIntramuscular | Aripiprazole | US FDA | Available on request |
| Abilify Asimtufii 960 mg/3.2 mL extended-release injectable suspensionIntramuscular | Aripiprazole | US FDA | Available on request |
| Abilify Maintena kit | Aripiprazole | US FDA | Available on request |
| Rexulti kit | Brexpiprazole | US FDA | Available on request |
| Rexulti 0.25 mg tabletOral | Brexpiprazole | US FDA | Available on request |
| Rexulti 0.5 mg tabletOral | Brexpiprazole | US FDA | Available on request |
| Rexulti 1 mg tabletOral | Brexpiprazole | US FDA | Available on request |
| Rexulti 2 mg tabletOral | Brexpiprazole | US FDA | Available on request |
| Rexulti 3 mg tabletOral | Brexpiprazole | US FDA | Available on request |
| Rexulti 4 mg tabletOral | Brexpiprazole | US FDA | Available on request |
Cardiology
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Jynarque kit | Tolvaptan | US FDA | Available on request |
| Jynarque 15 mg tabletOral | Tolvaptan | US FDA | Available on request |
| Jynarque 30 mg tabletOral | Tolvaptan | US FDA | Available on request |
| Samsca 15 mg tabletOral | Tolvaptan | US FDA | Available on request |
| Samsca 30 mg tabletOral | Tolvaptan | US FDA | Available on request |
Neurology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Nuedexta 20 mg/10 mg capsuleOral | Dextromethorphan and Quinidine | US FDA | Available on request |
Other products
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Simtriyo 140 mg extended-release capsuleOral | Centanafadine | US FDA | Available on request |
| Simtriyo 210 mg extended-release capsuleOral | Centanafadine | US FDA | Available on request |
| Simtriyo 280 mg extended-release capsuleOral | Centanafadine | US FDA | Available on request |
| Voyxact 400 mg/2 mL injectionSubcutaneous Cold chain | Sibeprenlimab | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Otsuka America Pharmaceutical
Send a request for any of these products. We confirm the licensed source, documents and lead time.